Stock Market News — May 15, 2026 — Friday Evening (last 12 hours, Pacific Time)

Executive Summary

Wall Street closed a volatile week firmly in the red, with the Dow falling 1.07% as a global bond sell-off sent the 30-year Treasury yield to its highest level since 2007, rattling equities across the board. The week's single most important development was SpaceX's accelerated IPO timeline — targeting a June 12 Nasdaq listing with a 5-for-1 stock split already approved — marking what could be the most consequential public offering in years. Meanwhile, Berkshire Hathaway's 13-F filings revealed a major rotation into Delta Air Lines and out of Amazon, UnitedHealth, Visa, and Mastercard, signaling a notable shift in Buffett's portfolio priorities.

Sentiment Breakdown

Net Sentiment: Bearish — A surging bond market, broad global equity declines, regulatory headwinds on tech, and tariff-related lawsuits dominated the day's narrative, overwhelming pockets of IPO optimism and deal activity.

Top Market-Moving Headlines

🔴 Macro/Bonds | Treasury yields soar as bond sell-off grips markets; US30Y hits highest since 2007
Market Impact: The 30-year yield hitting levels not seen since 2007 is the week's most systemic risk signal, tightening financial conditions across equities, real estate, and credit markets.

🔴 Equities | Stocks end roller-coaster week on a negative note amid steep global bond sell-off
Market Impact: The Dow fell 1.07%, with Basic Materials, Utilities, and Industrials leading losses — a broad-based retreat that erased much of the prior week's tariff-truce rally.

🟢 IPO/Space | SpaceX accelerates IPO timeline, targets June 12 listing on Nasdaq
Market Impact: A confirmed Nasdaq listing date and 5-for-1 stock split approval make this the most anticipated IPO in years, with massive implications for retail and institutional participation.

🟢 IPO/Space | SpaceX shareholders approve 5-for-1 stock split
Market Impact: The split lowers the per-share price ahead of the IPO, broadening the potential investor base and signaling board confidence in the listing's momentum.

🟢 Portfolio/Airlines | Berkshire buys Delta, more Alphabet; sheds Amazon, UnitedHealth, Visa and Mastercard
Market Impact: A $2.65B new stake in Delta is a strong endorsement of the airline sector's recovery; the exit from Visa, Mastercard, and UnitedHealth is a significant signal worth watching for sector rotation.

🔴 Semiconductors/Regulatory | Arm Holdings to face US antitrust probe over chip tech
Market Impact: An FTC antitrust probe into Arm's licensing practices is a material overhang for the stock and could disrupt the broader semiconductor ecosystem that depends on Arm's architecture.

🔴 Tech/Legal | Consumers sue Amazon for not refunding Trump tariff costs
Market Impact: A class-action lawsuit over tariff pass-throughs adds legal and reputational risk to Amazon at a time when consumer sentiment is already fragile.

🟢 Defense/Aerospace | Trump says China to buy 200 Boeing jets, order could rise up to 750
Market Impact: A potential 750-plane order from China would be transformational for Boeing's order book and a major positive for the aerospace supply chain.

🔴 Macro/Europe | Germany DAX down 2.05%; STOXX 600 logs weekly losses on Iran war-linked inflation woes
Market Impact: Europe's broad sell-off, led by Germany's 2.05% DAX drop, reflects compounding pressures from inflation fears tied to geopolitical tensions and rising bond yields.

🔴 Tech/Social Media | Ford shares sell off after two-day rally as Barclays says AI trade "overdone"
Market Impact: Barclays calling the AI-driven rally in Ford "overdone" is a broader warning shot for momentum trades in non-core AI names that surged on sentiment alone.

🟢 AI/Enterprise | PwC expands Anthropic alliance to deploy Claude across workforce
Market Impact: One of the Big Four deploying Claude at enterprise scale is a meaningful commercial validation for Anthropic and signals accelerating AI adoption in professional services.

🔴 Crypto | Why is Coinbase stock sliding today? — down 7.64%
Market Impact: A 7.64% intraday drop in Coinbase reverses prior session gains, reflecting crypto market volatility and broader risk-off sentiment hitting high-beta names hardest.

🟢 AI/Fintech | OpenAI enters personal finance with GPT-5.5 integration; stocks hit
Market Impact: ChatGPT moving into personal finance is a direct competitive threat to fintech platforms and robo-advisors — watch names like Intuit, SoFi, and Betterment for spillover pressure.

🔴 Samsung/Labor | At Samsung, the global AI boom spurred a looming strike and deep divisions
Market Impact: An 18-day strike threat at Samsung could disrupt chip supply chains at a critical moment for AI hardware demand, adding to semiconductor sector uncertainty.

🟢 IPO | Cerebras Systems closes $6.38 billion IPO on Nasdaq
Market Impact: A $6.38B IPO closing at $185/share for an AI chip company is a strong signal that institutional appetite for AI infrastructure plays remains robust despite the broader market pullback.

🔴 Healthcare/Biotech | Amgen stock falls 2.1% after Kissei warns on Tavneos liver risks
Market Impact: Liver risk warnings on a key drug create regulatory and commercial uncertainty for Amgen, with potential implications for the rare disease treatment pipeline.

🔴 Regulatory/FDA | FDA drug center head expected to leave after commissioner's exit
Market Impact: Leadership instability at the FDA's drug center raises approval timeline uncertainty for biotech and pharma companies with pending applications.

🟡 Hedge Funds/13-F | Ackman, Loeb take different routes on tech bets in early 2026
Market Impact: Diverging strategies from two high-profile managers highlight the lack of consensus on tech valuations — a useful read on smart money positioning heading into Q2.

🟢 Semiconductors/China | Deepwater's Munster sees Nvidia stock upside from China sales
Market Impact: U.S. approval to sell H200 GPUs to ~10 Chinese firms opens a meaningful revenue channel for Nvidia that the market may not have fully priced in.

🟡 Legal/Social Media | YouTube, Snap and TikTok settle school district's social media addiction claims
Market Impact: Settlements remove a legal overhang for these platforms but set a precedent that could invite further litigation from other school districts and municipalities.

Market Implications

The dominant risk heading into next week is the bond market. The 30-year Treasury yield hitting its highest level since 2007 is not a one-day story — it reflects persistent inflation anxiety, fiscal deficit concerns, and a market that is no longer confident the Fed has room to cut. Equities that rallied on rate-cut hopes are most vulnerable, and the broad global sell-off (DAX -2.05%, FTSE -1.77%, CAC -1.60%, Dow -1.07%) suggests this is a coordinated repricing of risk, not a U.S.-specific event. Watch Monday's TIC data and housing market index for further signals on foreign demand for U.S. debt and rate sensitivity in the real economy.

The SpaceX IPO is the week's most consequential forward-looking event. A June 12 Nasdaq listing with a 5-for-1 split already approved will dominate headlines and could absorb significant liquidity from other growth names. Institutional investors who have been building semiconductor and AI infrastructure positions (per 13-F filings) may face allocation decisions between SpaceX and existing holdings. Cerebras' successful $6.38B IPO this week suggests the window is open — but rising yields could narrow it quickly.

Berkshire's portfolio moves deserve careful attention as a sector signal. The simultaneous exit from Visa, Mastercard, UnitedHealth, and Amazon — while adding Delta and Macy's — reads as a rotation from high-multiple, defensive-growth names into beaten-down cyclicals. Combined with Ares Management bulking up on credit funds and institutions broadly raising private credit exposure, the smart money appears to be repositioning for a higher-for-longer rate environment where real assets and cash-generative cyclicals outperform.

Vlad's Key Takeaways

• $SPX / Dow — Down 1.07% on the week's final session; the bond sell-off, not earnings, is now the primary market driver.
• US30Y Treasury — Hit highest yield since 2007; a systemic risk signal that tightens conditions across all asset classes.
• $SPCE / SpaceX — June 12 Nasdaq IPO target with 5-for-1 split approved; the most anticipated listing in years is now imminent.
• $DAL (Delta) — Berkshire's $2.65B new stake is a strong fundamental endorsement of airline sector recovery.
• $BRK.A (Berkshire) — Exited Visa, Mastercard, Amazon, and UnitedHealth; a major portfolio rotation signal worth tracking.
• $ARM (Arm Holdings) — FTC antitrust probe is a material new overhang for the stock and chip licensing ecosystem.
• $AMZN (Amazon) — Hit by both Berkshire's exit and a new consumer class-action lawsuit over tariff cost pass-throughs.
• $BA (Boeing) — Potential 200–750 jet order from China is transformational if it materializes; watch for confirmation.
• $NVDA (Nvidia) — H200 GPU sales approved for ~10 Chinese firms; Deepwater's Munster sees unpriced upside.
• $COIN (Coinbase) — Fell 7.64% intraday, reversing prior gains; high-beta crypto names are absorbing outsized risk-off pressure.
• $AMGN (Amgen) — Down 2.1% on Tavneos liver risk warnings; drug-specific headline risk in an already volatile biotech tape.
• $F (Ford) — Fell 7%+ as Barclays called the AI-driven rally "overdone"; a warning for momentum trades in non-core AI names.
• Cerebras Systems — Closed a $6.38B IPO at $185/share; confirms institutional appetite for AI chip infrastructure remains strong.
• Samsung — Looming 18-day strike threatens chip supply chains at a critical moment for AI hardware demand.
• OpenAI / ChatGPT — GPT-5.5 personal finance integration is a direct competitive threat to fintech and robo-advisor platforms.
• $DXCM (DexCom) — Surged 7.21% on positive corporate developments; a rare bright spot in an otherwise red session.
• PwC / Anthropic — Enterprise-scale Claude deployment by a Big Four firm validates Anthropic's commercial trajectory.
• European Markets — DAX -2.05%, FTSE -1.77%, CAC -1.60%; Iran-linked inflation fears and UK political turmoil compounded bond pressure.
• FDA Leadership — Drug center head expected to exit; approval timeline uncertainty rises for biotech names with pending applications.
• Private Credit — Institutions raised exposure while retail investors pulled back; a divergence worth monitoring as yields climb.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/